Bailard’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-228,000
| Closed | -$816K | – | 540 |
|
|
2019
Q1 | $816K | Buy |
228,000
+12,000
| +6% | +$42.9K | 0.05% | 243 |
|
|
2018
Q4 | $827K | Buy |
216,000
+146,000
| +209% | +$559K | 0.06% | 233 |
|
|
2018
Q3 | $662K | Buy |
+70,000
| New | +$662K | 0.04% | 291 |
|
|
2016
Q4 | – | Sell |
-215,000
| Closed | -$740K | – | 302 |
|
|
2016
Q3 | $740K | Hold |
215,000
| – | – | 0.07% | 183 |
|
|
2016
Q2 | $748K | Hold |
215,000
| – | – | 0.09% | 172 |
|
|
2016
Q1 | $888K | Buy |
+215,000
| New | +$888K | 0.12% | 115 |
|
|
2015
Q4 | – | Sell |
-215,000
| Closed | -$1.31M | – | 204 |
|
|
2015
Q3 | $1.31M | Buy |
215,000
+76,000
| +55% | +$463K | 0.2% | 76 |
|
|
2015
Q2 | $1.65M | Hold |
139,000
| – | – | 0.25% | 70 |
|
|
2015
Q1 | $2.43M | Buy |
139,000
+59,000
| +74% | +$1.03M | 0.34% | 46 |
|
|
2014
Q4 | $1.21M | Buy |
+80,000
| New | +$1.21M | 0.17% | 88 |
|
|
2014
Q2 | – | Sell |
-95,500
| Closed | -$2.05M | – | 235 |
|
|
2014
Q1 | $2.05M | Sell |
95,500
-20,295
| -18% | -$436K | 0.33% | 51 |
|
|
2013
Q4 | $923K | Buy |
+115,795
| New | +$923K | 0.15% | 89 |
|